AKT1 and cancer: As shown in Figure 13, within the PI3K-AKT signaling pathway, the evolution of phosphoprotein expression from absent/weak (normal) to focal enhancement (leukoplakia, especially in areas of dysplasia) to diffuse strong positivity (cancer) indicates progressively increasing pathway activity.